Stocksigma LogoStocksigma Logo

Indoco’s CRO AnaCipher Secures ANVISA Brazil Regulatory Approval

Indoco Remedies announced that its clinical research organisation, AnaCipher, received regulatory approval from Brazil’s ANVISA for its clinical and

Indoco’s CRO AnaCipher Secures ANVISA Brazil Regulatory Approval

Indoco Remedies Ltd · Press Release · 27 Oct 2026, 9:07 pm

Indoco’s CRO AnaCipher Secures ANVISA Brazil Regulatory Approval Indoco Remedies announced that its clinical research organisation, AnaCipher, received regulatory approval from Brazil’s ANVISA for its clinical and bioanalytical facilities following an inspection conducted from 30th Mar'26 to 7th Apr'26. The approval authorizes AnaCipher to conduct Bioavailability and Bioequivalence studies and provide bioanalytical support for regulatory submissions in Brazil. This clearance strengthens AnaCipher’s international compliance profile, enabling Indoco to expand its contract research services across Latin American markets and support global pharmaceutical clients.

Original exchange filing (PDF)

More announcements from Indoco Remedies Ltd

All Indoco Remedies Ltd announcements